| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |